Perspective Therapeutics, Inc. — Director's Dealing 2023

Mar 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (ISR)
CIK: 0000728387
Period of Report: 2023-02-21

Reporting Person: Williamson Robert F III (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-21	Stock Options (right to buy)	$0.38	A	470000	Acquired	2033-02-21	Common Stock (470000)	Direct
2023-02-21	Stock Options (right to buy)	$0.38	A	230000	Acquired	2033-02-21	Common Stock (230000)	Direct

Footnotes

F1: Vest monthly over three years.

F2: 100% vests 2/21/2024.